Skip to main content

Research News

  • Researchers have successfully engineered E coli bacteria to produce new forms of antibiotics — including three that show promise in fighting drug-resistant bacteria. Blaine A Pfeifer, an associate professor of chemical and biological engineering in the University at Buffalo School of Engineering and Applied Sciences, has been studying how to engineer Escherichia coli (E coli) to generate new varieties of erythromycin, a popular antibiotic.

  • Everybody loves  chocolate.  A new research found tentative evidence that eating chocolate in modest quantities may be good for the heart. Heart researchers at the University of Aberdeen found that eating up to 100g of chocolate a day lowered the risk of and reduced the risk of suffering a stroke by 23 per cent. The study is published in the Heart.

  • Memories that are 'lost' as a result of traumatic injury, stress or diseases such as Alzheimer's can be recalled by activating brain cells with light, MIT scientists, including one of Indian-origin, have found. Researchers were able to reactivate memories that could not otherwise be retrieved, using a technology known as optogenetics.

  • Novel drug 'ixekizumab' miracle for Psoriasis

    People suffering from psoriasis reported quick and extensive improvement of the psoriasis skin condition with new drug. The study published in The Lancet journal. 40% of people reported a complete clearance of psoriatic plaques after 12 weeks of treatment with the new drug and over 90% showed improvement.

  • Prognosis for breast cancer is relatively good when detected in its early stages, metastatic disease is the cause of 90 percent of all cancer-related deaths. Breast cancer patients with high levels of the protein activin-like receptor kinase (ALK1) in the blood vessels of their tumors were more likely to develop metastatic disease, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.

  • Acute myeloid leukemia is a type of cancer of the blood and bone marrow that affects immature blood cell growth.It is fatal within five years for 90% of seniors over 65 years of age. Adding University of Waterloo scientists have found that the nutritious fruit may hold the key to beating deadly leukemia. They have discovered a lipid in avocados that combats AML by targeting the root of the disease - leukemia stem cells. The research is published in the Cancer Research.

  • A Study says, Peanuts can enhance your lifespan and lower mortality rates, but finds no protective effect for peanut butter.  The effects are equal in men and women. Nut consumption was assessed by asking about portion size and frequency of intake of peanuts, other nuts (tree nuts) and peanut butter. Men and women who eat at least 10 grams of nuts or peanuts per day have a lower risk of dying from several major causes of death than people who do not consume nuts or peanuts, the study said. The study was published in the International Journal of Epidemiology.

  • Scientists identified a gene by whose mutation is linked to the development of an aggressive form of brain cancer. An error in a gene called TCF12 is associated with more aggressive forms of a disease called anaplastic oligodendroglioma. The TCF 12 is the genetic code for a protein that binds to DNA and controls the activity of other genes. The study published in the journal Nature Communications.

  • Cervical cancer is the fourth commonest cause of cancer among women, and tragically is often diagnosed too late. Cervical cancer is a type of cancer that develops in a woman's cervix (the entrance to the womb from the vagina). It is caused by the human papillomavirus (HPV) which is easily spread by sexual intercourse. Cervarix is a vaccine against certain types of cancer-causing human papillomavirus (HPV). Currently, Cervarix, which with another vaccine, Gardasil, is being rolled out to shield young people from HPV. A new study has found that a single vaccine shot, rather than the recommended triple dose, may be enough to protect women against cervical cancer.  The new research is published in the The Lancet Oncology.

Subscribe to Research News